Wednesday, February 29, 2012

FDA adds diabetes, memory loss warnings to statins | Reuters

FDA adds diabetes, memory loss warnings to statins Reuters: Health regulators are adding warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to say they may raise levels of blood sugar and could cause memory loss.

Blood sugar treatment may protect brain cells from Alzheimer's - Mirror Online

Blood sugar treatment may protect brain cells from Alzheimer's - Mirror Online: Alzheimer's disease could be cured by preventing low blood sugar in the brain, scientists revealed yesterday.
They experimented on mice using a chemical to maintain the supply of blood glucose to brain cells – and found it helped tostop dementia.
Chemical biologist Prof David Vocadlo and his team at the Simon Fraser University in Canada, genetically programmed mice to develop Alzheimer’s before injecting them with the chemical called Thiamet-G.

Walnuts May Boost Memory and Improve Cognitive Function: New Results from Landmark... -- FOLSOM, Calif., Feb. 29, 2012 /PRNewswire/ --

Walnuts May Boost Memory and Improve Cognitive Function: New Results from Landmark... -- FOLSOM, Calif., Feb. 29, 2012 /PRNewswire/ --: The study reported regular consumption of walnuts, but not of other nuts, was associated with better working memory. The investigators believe that the high polyphenol (antioxidant) content found in walnuts may be one of the key elements in helping to preserve cognition and fight age-related cognitive decline. Coffee, virgin olive oil and wine were also associated with better cognitive scores.

Monday, February 27, 2012

Anti-oxidant Therapy Presents a Promising Strategy in Prevention or Delaying the Onset and Progression of Alzheimer - seattlepi.com

Anti-oxidant Therapy Presents a Promising Strategy in Prevention or Delaying the Onset and Progression of Alzheimer - seattlepi.com: A newly published study, in Free Radical Biology and Medicine, provides direct evidence between increased oxidative damage and pathological responses in early memory deficits (pre-plaque) stage of Alzheimer Disease. Nutri-Med Logic Corp, agreeing with this study, adds that inadequate anti-oxidant defense is a precedent condition in Alzheimer, thus, highlighting the importance of an early anti-oxidant diet, as a therapeutic intervention. However, an early anti-inflammatory diet would be as important as the anti-oxidant diet.

Researchers test sugary solution to Alzheimer’s

Researchers test sugary solution to Alzheimer’s: Slowing or preventing the development of Alzheimer’s disease, a fatal brain condition expected to hit one in 85 people globally by 2050, may be as simple as ensuring a brain protein’s sugar levels are maintained.

Medical News:Reduced Omega-3 Speeds Brain Aging - in Neurology, Dementia from MedPage Today

Medical News:Reduced Omega-3 Speeds Brain Aging - in Neurology, Dementia from MedPage Today: Lower blood levels of omega-3 fatty acids are associated with smaller brain volumes and worse cognitive performance, researchers reported.
The structural findings suggest that people with low levels of the nutrients -- found mainly in fish -- have brains that appear to have aged faster than normal, according to Zaldy Tan, MD, of the University of California Los Angeles, and colleagues.

Thursday, February 23, 2012

foodconsumer.org - Red grape juice may help fight Alzheimer's disease

foodconsumer.org - Red grape juice may help fight Alzheimer's disease: Thursday Fed 22, 2012 (foodconsumer.org) -- A new study in Journal of Isfahan Medical School in Iran suggests that eating red grapes or drinking red grape juice regularly can help fight Alzheimer's disease.

Alzheimer's drug may impair memory | Fox News

Alzheimer's drug may impair memory Fox News: A class of drugs being investigated to treat Alzheimer's disease may actually have the opposite effect of the original intent — they may impair memory, a new study in animals suggests.
The drugs, known as BACE1 inhibitors, are designed to prevent the formation of the protein plaques in the brain that are a hallmark of Alzheimer's disease. However, the new study suggests these drugs interfere with the brain's wiring, potentially affecting the formation of new memories.

Alzheimer's Disease: Skin Cancer Drug Sparks Hope, Desperation - ABC News

Alzheimer's Disease: Skin Cancer Drug Sparks Hope, Desperation - ABC News: Because bexarotene is already approved by the U.S. Food and Drug Administration for skin cancer, doctors can legally prescribe it "off-label" for other conditions. But Alzheimer's experts urge families to temper their hope until the drug is proved safe and effective by years of clinical trials -- a tall order for the country's 5.4 million patients and 14.9 million caregivers.

Wednesday, February 22, 2012

Why I've created this blog.

My father, grandfather, and at least one uncle had Alzheimer’s.  I’m not afraid of dying; but I am afraid of Alzheimer’s.  You can find information about me in my first posting.  Alzheimer’s is not my expertise; but I do know something about research and I keep up on the news.  This is where you can find what appears to be credible research and news.  Subscribe to the blog and become a follower to keep up on the latest information and news, both good and bad.
Both my father and grandfather and possibly an uncle died with alzheimer's.   Please use this as a place for discussions and questions and answers.

Friday, February 10, 2012

A Cancer Drug Reverses Alzheimer's Disease in Mice | Healthland | TIME.com

A Cancer Drug Reverses Alzheimer's Disease in Mice Healthland TIME.com: Researchers at Case Western Reserve University have discovered that a drug currently used to treat cancer patients can reverse the cognitive deficits related to Alzheimer’s disease in mice, and what’s more, it accomplishes this feat in a remarkably short period of time.
The drug, called bexarotene, has been approved for the treatment of a type of skin cancer since 1999. In the new experiments with genetically engineered mice, the drug quickly cleared away the beta-amyloid plaques in the brain that are believed to cause cognitive deficits in Alzheimer’s disease.

Thursday, February 9, 2012

Electric shocks to brain may boost memory: Study - HealthPop - CBS News

Electric shocks to brain may boost memory: Study - HealthPop - CBS News: The study recorded brain activity in seven epilepsy patients who had already had electrodes implanted in their brains to monitor the origin of their seizures. These patients played a video game in which they had to learn the location of stores in a virtual city. UCLA neuroscientists found that participants remembered the locations better after they received mild zaps of electricity in their brains.

Saturday, February 4, 2012

A New Target In Fighting Brain Diseases: Metals - WSJ.com

A New Target In Fighting Brain Diseases: Metals - WSJ.com: Iron and copper appear to accumulate beyond normal levels in the brains of people with these diseases, and a new, Australian study published Sunday shows reducing excess iron in the brain can alleviate Alzheimer's-like symptoms—at least in mice.
A genetic mutation related to regulating iron is linked to ALS, or Lou Gehrig's disease. Zinc, on the other hand, appears to impair memory if its levels get too low or if it gets into a brain region where it doesn't belong, as it can with traumatic brain injury.

Alzheimer's disease "jumps" across brain cells to spread - HealthPop - CBS News

Alzheimer's disease "jumps" across brain cells to spread - HealthPop - CBS News: The study found that tau protein, which indicates the fibrous tangles found in the brains of Alzheimer's patients, spreads along the brain's neurons from one region to the other - resulting in severe dementia. The new clues to the neurodegenerative brain disorder might help scientists find a way to stop the disease from getting worse.

Lilly Alzheimer's drug an unlikely ace in the hole | Reuters

Lilly Alzheimer's drug an unlikely ace in the hole Reuters: Lilly's latest contender, solanezumab, is designed to bind to and mop up a protein called amyloid beta, the main component of amyloid plaque deposits in the brains of patients with Alzheimer's disease.
Anticipation over the drug has built up slowly. Lilly is expected to release as soon as this summer final data from two 18-month studies of the treatment. Earlier this week, the company said an independent safety monitor had given researchers the green light to continue with the late-stage trials.

Wednesday, February 1, 2012

Sharjah discoveries could help fight Alzheimer's and breast cancer - The National

Sharjah discoveries could help fight Alzheimer's and breast cancer - The National: SHARJAH // Chemical compounds that could combat the cells responsible for Alzheimer's disease and breast cancer have been discovered in a groundbreaking research project by local academic institutions.
Two separate three-year studies conducted by the University of Sharjah, the Sharjah Medical Research Institute and the Sharjah Academy for Scientific Research have found 15 compounds that have the potential to fight cells that cause Alzheimer's and three compounds that could combat cells responsible for the progression of breast cancer.